NIAID Small Business Biodefense ProgramFY 2003 Awards | Institution | PI Name | Title |
|---|
| Antibody Science, Inc. | Herrmann, John E | Therapeutic Antibodies for Lethal Anthrax Infection | | Biosense Technologies, Inc. | Rieder, Ronald J | Rapid Antibiotic Susceptibility Testing | | Elitra Pharmaceuticals, Inc. | Trawick, John D | A Novel Platform to Discover Biodefense Therapeutics | | Eragen Biosciences, Inc. | Prudent, James R | Rapid Turn-Around Multiplex Testing: Bioweapon Agents | | Genebact Biotechnologies, Inc. | Willeford, Kenneth O | Biowarfare Applications of a New Immunoregulator | | Genome Therapeutics Corporation | Moir, Donald T | Discovery of B. pseudomallei Therapeutics for Biodefense | | Hepadnavirus Testing, Inc. | Marion, Patricia L | New Broad-Spectrum Antivirals: Target Bunyaviruses | | Iogenetics, LLC | Imboden, Michael | Antibody-Biocide Fusions to Control Cryptosporidium | | Macrogenics, Inc. | Sykes, Kathryn F | Vaccine Discovery for Burkholderia via Protection Screen | | Molecular Express, Inc. | Ernst, William A | Universal Influenza Matrix 2 Subunit Vaccine | | Molecular Therapeutics, Inc. | Sunkara, Prasad S | Hexa-D-Arg: A Furin Inhibitor for Anthrax Biodefense | | Molsoft, LLC | Totrov, Maxim | Rational Design of Inhibitors of Yersinia pestis EF-Tu | | Neurobiotex, Inc. | Frederickson, Christopher J | High-Speed Microfluidic Sorting of Biohazardous Cells | | Nexbio, Inc. | Yu, Mang | Broad-Spectrum Therapeutics for Influenza | | Nomadics, Inc. | Clarke, Jean M | Polymer-Based Yersinia Pestis Point-of-Case Diagnostics | | Perlegen Sciences, Inc. | Sparks, Andrew B | Discovery of Salmonella Signature SNPs by Microarrays | | Planet Biotechnology, Inc. | Wycoff, Keith L | Immunotherapy for Pulmonary Anthrax | | Redstorm Scientific, Inc. | Whitten, Steven | Antiviral Agents directed at West Nile Virus | | TSRL, Inc. | Hilfinger, John M | Improving Absorption and Targeting of Antiviral Drugs |
back to top |